Table 2.
Complex | MNP size (nm) | Complex size | Magnetic field strength (T) | Concentration | Function | Main Results | Model | Ref. |
---|---|---|---|---|---|---|---|---|
Magnetic microrods loaded with t-PA | 15 ± 3 | Length 1.3 ± 0.2 μm, Diameter 0.5 ± 0.1 μm | 0.24 | 1mg/kg | To enhance thrombolysis | Reduction in t-PA thrombolysis time by 2/3 | dMCAO/mouse | [87] |
MNP loaded with rt-PA | \ | \ | \ | 1mg/ml | To enhance thrombolysis | Dramatic increase in thrombolytic efficiency | dMCAO/mouse | [88] |
PLGA-coated disc-shaped particles loaded with rt-PA and SPION | 10.7 | Pitch 973.8 nm, Diameter 2.67 μm | 0.42 | 2mg/kg | To avoid hemorrhagic transformation |
Durable thrombolysis and avoidance of HT | Laser-induced thrombosis/mouse | [89] |
Platelet membrane mimetic magnetic nanocarriers loaded with L-arginine | 27.94 ± 1.10 | Diameter 200 nm | 0.3 | (1.41 ± 0.16)×108/ml | To improve blood flow | Rapid targeting and successful reestablishment of blood flow | Cold light source-induced focal cerebral ischemia/mouse | [90] |
Magnetic extracellular nano-vesicles | 12 | Diameter 194.2 ± 44.5 nm | 0.32 | 200μg in 300 μl of PBS | To repair infarcted tissue | Significant reduction in cerebral infarct volume | Transient MCAO/rat | [91] |
Silica-coated MNP-labeled endothelial progenitor cells | 60 | \ | 0.39 | 1 × 106 in 100 μl of PBS | To enhance the targeting of EPCs | Enhanced aggregation of EPCs in the infarct border zone | LAD ligation/rat | [92] |
Magnetic extracellular nano-vesicles | 25 | \ | \ | 150μg per rat | To repair infarcted tissue | Improvement in heart function | LAD ligation/rat | [93] |
MNP loaded with CD63 and MLC antibodies | 200 | \ | 1.3 | 10mg/kg | To capture circulating exosomes | Successful capture and aggregation of exosomes | LAD ligation/rat and rabbit | [6] |
Peptide functionalized SPION loaded with melatonin | 10 | Diameter 221 ± 13nm | 0.6 | \ | To improve cardiac hypertrophy | Prolonged melatonin half-life and increased utilization | TAC/rat | [94] |
Fe3O4 nanoparticles loaded with OM | 45 | Diameter 45 nm | 0.3 | 4mg per rat | To reduce side effects | 118% cardiac efficacy achieved with 4% of previous dose | Heart failure/rat | [95] |
SPION-labeled mesenchymal stem cell | 40 | \ | 0.3 | 2 × 106 in 0.5 ml of DMEM | To enhance tissue regeneration | Significant reduction in myocardial fibrosis | ISO subcutaneous injection/rat | [96] |
PLGA-MNP loaded with CaCl2 | 213 ± 84 | Diameter 213 ± 84nm | 0.26 | 1mg/ml | To ablate the major atrial GP | Successful suppression of target GP function | RAP/dog | [97] |
Abbreviations: MNP: magnetic nanoparticle; PLGA: poly(lactic-co-glycolic acid); SPION: superparamagnetic iron oxide nanoparticle; OM: omecamtive mecarbil; DMEM: Dulbecco’s modified Eagle’s medium; EPCs: endothelial progenitor cells; GP: ganglionated plexi; HT: hemorrhagic transformation; (d)MCAO (distal): middle cerebral artery occlusion, LAD: left anterior descending artery; TAC: transverse aortic constriction; ISO: isoproterenol; RAP: rapid atrial pacing.